Rapid Identification of Drug Mechanisms with Deep Learning-Based Multichannel Surface-Enhanced Raman Spectroscopy.

Area of Science:

• Biomedical Engineering
• Analytical Chemistry
• Computational Biology

Background:

• Accurate identification of chemotherapeutic drug mechanisms is crucial for effective cancer treatment and drug development.
• Existing methods for drug mechanism identification can be time-consuming and lack high dimensionality.

Purpose of the Study:

• To develop a rapid and accurate method for identifying chemotherapeutic drug mechanisms using a novel sensor array.
• To leverage deep learning for high-dimensionality analysis of drug-induced cellular changes.

Main Methods:

• Development of a multichannel surface-enhanced Raman scattering (SERS) sensor array utilizing self-assembled monolayers (SAMs).
• Application of deep learning, specifically convolutional neural networks (CNNs), to analyze multidimensional SERS data.
• High-dimensionality fingerprinting of drug-induced molecular changes within cells.

Main Results:

• The SERS sensor array generated diversified spectral signatures reflecting drug-induced cellular modifications.
• The trained CNN model achieved a discriminatory accuracy of approximately 99% in identifying drug mechanisms.
• Demonstrated the platform's capability for rapid and precise drug mechanism identification.

Conclusions:

• The developed SERS sensor array combined with deep learning offers a powerful tool for rapid drug mechanism identification.
• This platform can significantly enhance drug screening, characterization, and accelerate the overall drug development process.
• Potential to expand the analytical toolbox for pharmaceutical research and personalized medicine.